Rehabilitation for paraplegia has been trapped in repetition: treadmills, crutches, slow gains measured in inches. That era is ending.

The EFeQT study — funded by Germany’s Federal Joint Committee (G-BA) with treatment costs covered by statutory health insurance — will test whether neuromuscular feedback therapy can outperform conventional physiotherapy on walking ability in patients with incomplete paraplegia.

This study is the newest to run on the disease-agnostic Huma Cloud Platform — the backbone of modern digital health software.

We are proud to empower their work in this disease area, and to prove again that regulated, healthcare software can be deployed at speed and at scale.